Microplastics and the plastic chemicals they carry, bisphenol A and the phthalates, are now found throughout the body and the wider environment. Detection is close to universal: plastic particles have been measured in human blood and placenta, and BPA and phthalates turn up in the urine of almost everyone tested. Detection is exposure, not proven harm.
The strongest health signal is that BPA and phthalates act on hormones, with well-characterized effects in animals and worrying associations in people, most consistently in male reproductive development. A 2024 study linked microplastics in artery plaque to later heart attacks and strokes, a striking result that comes from one cohort and is an association. Cutting packaged and plastic-contact food measurably lowers your levels within days.
Findings & Outcomes
What They Are
Two different exposures come from plastics, and it helps to keep them separate. There are the particles, microplastics and the far smaller nanoplastics, and there are the chemicals that plastics are built from or carry, above all bisphenol A and the phthalates. The particles are the newer, more uncertain science. The chemicals are the older, better-understood one, and they hold the strongest evidence of harm.
Microplastics are plastic fragments smaller than five millimeters, and nanoplastics are the fraction below one micrometer, small enough to cross membranes that larger particles cannot. They form as larger plastics weather and shed, and some are made small on purpose. We take them in mostly through food and drink, through indoor air where synthetic textiles and dust concentrate them, and through packaging that touches what we eat.
The chemical additives are a separate exposure. Bisphenol A (BPA) is the building block of polycarbonate plastic and the epoxy resins that line food and drink cans, and it leaches from those linings into food. Phthalates soften plastics and carry fragrance, so they appear in flexible packaging, vinyl, and many personal-care products. The bonds holding BPA into its resins can break down, and phthalates are not chemically locked into the plastic at all, so both migrate steadily into food, water and household dust. That migration is why exposure is so widespread.
What the Evidence Shows
Plastics are now measurable throughout the body. That is proof of exposure, not proof of harm, and the two have to be kept apart.
The evidence sits at four different strengths.
Detection is everywhere, and it is the newest, least-settled strand. Researchers have reported the first direct measurement of microplastics in human blood, quantifying plastic particles in the whole blood of most of a group of 22 healthy adults. A separate team found microplastics in placenta tissue, on both the maternal and fetal sides. And a 2024 imaging method counted nanoplastics in bottled water far above earlier estimates, on the order of 240,000 particles per liter, most of them nanoplastic-sized. These are small, method-building studies. They establish that the particles reach the body and are bioavailable, which is exposure, not a measured health effect.
The chemical exposure is better established. National US biomonitoring has detected BPA in the urine of more than nine in ten people and common phthalate breakdown products in most people tested, so everyday exposure is, for practical purposes, universal.
The endocrine activity is the best-established harm. BPA acts as a weak estrogen, an effect confirmed in laboratory systems and reported across a large body of animal work, often below the dose once treated as safe. Phthalates act in the opposite direction, as anti-androgens that interfere with testosterone. The clearest human evidence on phthalates and male reproductive development is the anogenital-distance research: boys whose mothers had higher prenatal phthalate levels tend to have a shorter anogenital distance, an androgen-sensitive marker, matching the animal finding. These human results are associations, and the developmental signal in boys is the most consistent of them.
The cardiovascular plaque signal is the striking new result. In a 2024 study of patients having plaque surgically removed from a neck artery, most plaque samples contained microplastics, and the patients whose plaque contained plastics went on to have markedly more heart attacks, strokes and deaths over the next three years. It is one cohort, in one type of patient, and it is observational, so it shows a strong association and cannot establish that the plastics caused the events. It is the first human outcome study of its kind, and it needs replication.
The industry-funding record explains part of the lag. When researchers tallied the low-dose BPA studies through 2005, the split by funding source was stark: more than nine in ten government-funded studies found significant effects, and none of the industry-funded ones did. That pattern is part of why the regulatory picture trailed the laboratory one for so long.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
How it works
BPA acts like a weak estrogen, with low-dose effects reported across many animal studies
BPA acts like a weak estrogen in the body, an effect shown clearly in lab and animal studies and linked to hormone-related changes in some human studies.
The estrogenic activity of BPA is confirmed in vitro, and vom Saal and Hughes counted low-dose effects in the great majority of independent animal studies, many below the reference dose then treated as safe. Rochester's review of the human literature reported associations between BPA exposure and reproductive, metabolic and developmental endpoints, of varying strength and consistency. The class-level endocrine activity is well supported; the magnitude and certainty of specific human effects at everyday exposure remain under study.
The studies · 2
Rochester, bisphenol A and human health: a review of the literature · Reprod Toxicol 2013;42:132-155
vom Saal and Hughes, an extensive new literature concerning low-dose effects of bisphenol A · Environ Health Perspect 2005;113(8):926-933
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
In rats, prenatal phthalate exposure lowers fetal testosterone and disrupts male development, the phthalate syndrome
In rats, phthalate exposure before birth cuts fetal testosterone and disrupts male reproductive development in a repeatable way researchers call the phthalate syndrome.
Gray and colleagues, who characterized the phthalate syndrome, used hormonal and RT-qPCR genomic biomarkers to define the adverse outcome pathway by which anti-androgenic phthalates suppress fetal Leydig-cell testosterone production and disrupt male rat reproductive tract development. The effect is dose-dependent and consistent across studies. It is animal evidence at controlled doses, and it supplies the mechanism behind the human anogenital-distance associations.
The study · 1
Gray et al., genomic and hormonal biomarkers of phthalate-induced male rat reproductive developmental toxicity, part II · Toxicol Sci 2021;182(2):195-214
Plastic particles were measurable in the blood of most of 22 healthy adults, averaging 1.6 micrograms per milliliter
In a study of 22 healthy adults, tiny plastic particles were measurable in the blood of most of them, the first direct evidence that plastics get into the bloodstream.
Leslie and colleagues built a double-shot pyrolysis GC/MS method for particles of at least 700 nm and applied it to whole blood from 22 healthy volunteers. Four high-production-volume polymers were identified: polyethylene terephthalate, polyethylene, polymers of styrene (a sum of polystyrene and related plastics), and poly(methyl methacrylate); polypropylene fell below the limit of quantification. The mean of the summed quantifiable concentration was 1.6 micrograms per milliliter. The sample is small and the work establishes that these particles are bioavailable for uptake into blood, not a health outcome or a dose-response.
The study · 1
Leslie et al., discovery and quantification of plastic particle pollution in human blood · Environ Int 2022;163:107199
Bottled water held about 240,000 plastic particles per liter, roughly 90 percent of them nanoplastic-sized
A new imaging method found on the order of 240,000 plastic particles per liter of bottled water, most of them nanoplastic-sized and too small for older methods to see.
Qian and colleagues developed single-particle stimulated Raman scattering microscopy, which identifies particles by their chemical fingerprint at high throughput, and applied it to bottled water from several brands. They counted about 2.4 (plus or minus 1.3) times ten to the fifth particles per liter, roughly 90 percent of which were nanoplastics smaller than one micrometer. That is orders of magnitude above prior microplastic-only estimates, because the smaller particles were previously invisible. The study characterizes what is present, not what any dose does in the body.
The study · 1
Qian et al., rapid single-particle chemical imaging of nanoplastics by SRS microscopy · Proc Natl Acad Sci U S A 2024;121(3):e2300582121
Microplastic fragments were found in 4 of 6 human placentas, on both the fetal and maternal sides
Microplastic pieces were found in four of six human placentas, on both the baby side and the mother side.
Ragusa and colleagues examined six placentas from consenting women with physiological pregnancies and found twelve microplastic fragments in four of them, spheric or irregular in shape and 5 to 10 micrometers in size, located on the fetal side, the maternal side and in the membranes. The particles were characterized by morphology and by Raman spectroscopy, and several carried pigments consistent with man-made coatings. It is a first observation of presence in a very small series.
The study · 1
Ragusa et al., Plasticenta: first evidence of microplastics in human placenta · Environ Int 2021;146:106274
Evidence And Methods
None of the industry-funded BPA studies found a low-dose effect, against more than 90 percent of government-funded ones
When researchers counted up the BPA safety studies, government-funded ones usually found effects and industry-funded ones did not, a stark split by who paid for the work.
vom Saal and Hughes reviewed the low-dose BPA literature and found that 94 of 115 studies reported significant effects, many below the 50 microgram per kilogram per day reference dose then treated as safe. Broken down by sponsor, more than 90 percent of government-funded studies reported significant effects while no industry-funded study did, and they noted industry studies that discounted positive controls or used insensitive designs. The paper documents a funding pattern and argues the safety assessment of the day was out of step with the independent evidence.
The study · 1
vom Saal and Hughes, an extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment · Environ Health Perspect 2005;113(8):926-933
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Environmental Exposure
Three days of fresh, unpackaged food cut BPA levels by 66 percent and phthalate metabolites by about half
Families who switched to fresh, unpackaged food for three days cut their BPA levels by about two thirds and their phthalate levels by about half.
Rudel and colleagues gave 20 participants in five families a three-day fresh-food intervention that avoided canned and plastic-packaged food, measuring urinary BPA and DEHP metabolites before, during and after. Geometric-mean BPA fell from 3.7 to 1.2 nanograms per milliliter (a 66 percent drop) and DEHP metabolites fell 53 to 56 percent, with maxima down 76 and 93 to 96 percent. It is small and short, and it shows that food contact drives a large, quickly reversible share of exposure.
The study · 1
Rudel et al., food packaging and bisphenol A and bis(2-ethylhexyl) phthalate exposure: findings from a dietary intervention · Environ Health Perspect 2011;119(7):914-920
Higher phthalate levels tracked with lower testosterone, about 29 percent lower in boys aged 6 to 12
In a national US survey, people with more phthalate breakdown products in their urine tended to have lower testosterone. The clearest single figure was a roughly 29 percent lower level in boys aged 6 to 12, and the strongest and most consistent associations were in women aged 40 to 60.
Meeker and Ferguson analyzed 2,208 NHANES 2011-2012 participants and found multiple phthalate metabolites associated with significantly reduced total testosterone across sexes and age groups. The strongest single numeric estimate was a 29 percent reduction (95% CI 6 to 47) in boys aged 6 to 12 for di-2-ethylhexyl phthalate metabolites; women aged 40 to 60 showed the strongest and most consistent inverse associations, and in adult men the inverse associations were confined to those aged 40 to 60. Because exposure and hormone were measured at the same time, this is an association, not a demonstrated cause.
The study · 1
Meeker and Ferguson, urinary phthalate metabolites and decreased serum testosterone in men, women and children, NHANES 2011-2012 · J Clin Endocrinol Metab 2014;99(11):4346-4352
Heart And Vascular
Patients with microplastics in carotid plaque had 4.5 times the risk of heart attack, stroke, or death (n=257)
In patients who had plaque removed from a neck artery, those with plastics detectable in the plaque were about four and a half times as likely to have a heart attack, stroke, or die over the next three years.
Marfella and colleagues ran a prospective, multicenter study of patients undergoing carotid endarterectomy. Of 257 who completed a mean 33.7-month follow-up, polyethylene was detected in the plaque of 150 (58.4 percent) by pyrolysis GC/MS, with polyvinyl chloride in 31; electron microscopy showed jagged foreign particles among plaque macrophages. Patients with plastics in plaque had a hazard ratio of 4.53 (95% CI 2.00 to 10.27, P<0.001) for the composite endpoint. It is the first human outcome study of its kind, and it is observational.
The study · 1
Marfella et al., microplastics and nanoplastics in atheromas and cardiovascular events · N Engl J Med 2024;390(10):900-910
The tiers are uneven. Hormone activity and male reproductive development rank higher because the mechanism is established and the animal work is strong. Particles in blood, placenta and water rank lower because they document presence, not effect. The cardiovascular row ranks as emerging, a single strong observation with its confounders named.
What You Can Do
Exposure responds quickly to what you do. When 20 people in five families ate only fresh, minimally packaged food for three days, their BPA levels fell by about two thirds and their phthalate metabolites by about half. Most of the exposure comes from food contact, which means most of it can be avoided.
Here is how to reduce plastic-chemical exposure, roughly in order of payoff:
- Keep heat away from plastic. Warmth speeds migration, so move food to glass or ceramic before microwaving, and let hot food cool before it goes into a plastic container.
- Favor fresh and frozen over canned and heavily packaged. Can linings are a major BPA source and flexible packaging carries phthalates, and whole foods avoid both.
- Choose glass, stainless steel or ceramic for storage, cooking and water bottles, and retire scratched or cloudy old plastic.
- Lean on filtered tap water where the local water is good, since bottled water carries a heavy nanoplastic load.
- Cut indoor dust, which concentrates phthalates from vinyl and synthetics: ventilate, damp-dust, and vacuum with a fine filter.
- Read personal-care labels, where fragrance often stands in for phthalates, and choose fragrance-free where you want to lower that source.
None of this needs to be total to matter. Exposure is universal and it drops fast when food contact changes, so even a few of these, kept up, lower your exposure.
How It Works
Both families of plastic chemicals work by imitating or blocking the body's own hormone signals. BPA binds the estrogen receptor and switches it on weakly, adding a faint estrogen signal in tissues that respond to estrogen. Phthalates lower the testosterone that fetal tissue needs to develop along the male pattern. In rats, prenatal exposure to certain phthalates suppresses fetal Leydig-cell testosterone and produces a reproducible set of male reproductive changes; researchers mapped that phthalate syndrome down to its hormonal and genomic steps. The timing of hormone signals matters most before birth and in early life, which is where the endocrine concern is concentrated.
Go Deeper
- Whole foods: fresh, minimally packaged eating is the single change that most lowers plastic-chemical exposure while doing a great deal else besides.
- Buying organic: where reducing chemical residues in food is worth the cost and where the money is better spent elsewhere.
- Seed oils: another food-processing question weighed at its evidence.
- Male fertility: where the phthalate and androgen evidence connects to reproductive health.
- How industry shapes science: the funding pattern behind the BPA safety record.
The Chinese Medicine View
Microplastics are a modern environmental exposure with no classical analog, and it would overreach to read them into the old texts. What the tradition did hold, by long observation, is that clean, unadulterated food and water are foundational, that the body has a finite capacity to transform what enters it, and that living in accord with a clean environment is part of staying well. The classics describe external influences that can lodge in the body, and they treat the Spleen and Stomach as the system that separates the clear and usable from the turbid. Read carefully, that is a general resonance with the reduction advice here, not a classical position on plastics. It aligns with Yang Sheng, the art of nourishing life, which counsels care about the quality of what you take in day after day.
Cautions
Everything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
BPA was detected in the urine of 92.6 percent of Americans, and common phthalate metabolites in more than 75 percent
Calafat and colleagues measured total urinary BPA in 2,517 NHANES 2003-2004 participants aged six and older and detected it in 92.6 percent, with levels varying by age, sex and race or ethnicity. Silva and colleagues measured seven phthalate monoester metabolites in NHANES 1999-2000 and found monoethyl phthalate, mono-n-butyl phthalate, monobenzyl phthalate and mono-(2-ethylhexyl) phthalate detectable in more than 75 percent of samples. Both are cross-sectional biomonitoring surveys that establish how widespread exposure is.Calafat et al., exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004Silva et al., urinary levels of seven phthalate metabolites in the U.S. population, NHANES 1999-2000
Boys with the highest prenatal phthalate exposure had about ten times the odds of a shorter anogenital distance (n=85)
Swan and colleagues measured nine phthalate monoester metabolites in prenatal maternal urine and examined 85 boys after birth. Four metabolites were inversely related to the anogenital index (anogenital distance divided by weight), and a summary phthalate score decreased the age-adjusted index in a dose-dependent way; boys in the top exposure quartile had an odds ratio of 10.2 (95% CI 2.5 to 42.2) for a shortened index. The pattern matches the incomplete-virilization picture seen in rodent phthalate work.Swan et al., decrease in anogenital distance among male infants with prenatal phthalate exposureBornehag et al., prenatal phthalate exposures and anogenital distance in Swedish boys
Exposure is universal, so aim for less, not zero
Everyone carries some plastic-chemical exposure, and how much the particles themselves affect health at everyday levels is still being worked out. The sensible response is steady reduction, the way you would treat cutting back on ultra-processed food, and not alarm.
Pregnancy and infancy are where minimizing matters most
The hormone effects fall hardest on development, and the most consistent human signal is in male reproductive development before birth. During pregnancy and early childhood, the low-cost packaging changes on this page are the ones most worth keeping up.
BPA-free does not mean well studied
When BPA is removed it is often replaced by close relatives such as BPS and BPF, which carry thinner safety data and appear to share some of the same hormone activity. Lowering plastic food contact overall is more reliable than swapping one additive for a close relative.
None of this needs to be total to matter, and the packaging moves are cheap and reversible. Treat it as sensible reduction, and consult a professional if you have specific concerns, especially in pregnancy.
Common Questions
How widespread is BPA and phthalate exposure?
About as widespread as it gets. National US surveys detected BPA in the urine of 92.6 percent of people tested and common phthalate breakdown products in more than three-quarters of samples. Spot urine reflects recent exposure and swings day to day, so a single reading is a rough gauge for one person, but the near-universal detection across the population is solid. Everyday exposure in an industrial society is effectively universal.
Is BPA an endocrine disruptor?
Yes, on the current evidence. BPA acts as a weak estrogen, an effect confirmed in laboratory systems and reported across a large body of animal work, often below the dose once treated as safe, and linked to hormone-related changes in some human studies. The class-level hormone activity is well established. What is still being worked out is how large the specific human effects are at everyday exposure.
Do phthalates lower testosterone?
The human evidence points that way, and it is associations, not trials. In a national US survey, higher phthalate breakdown products tracked with lower total testosterone across sexes and age groups, with a roughly 29 percent lower level in boys aged 6 to 12 for the DEHP group of phthalates. Because exposure and hormone were measured at the same time, this is an association, not a demonstrated cause. The animal evidence for phthalates lowering fetal testosterone is stronger and more direct.
Do microplastics cause heart attacks?
That is the open question a 2024 study put on the table, and it has not been settled. In patients who had plaque removed from a neck artery, those with microplastics in the plaque had about four and a half times the rate of heart attack, stroke, or death over the next three years. It is one cohort, in one type of patient, and it is observational, so it shows a strong association and cannot show that the plastics caused the events. People with plastics in their arteries may differ in diet, pollution exposure and other ways the study could not fully account for. It needs replication before the number is treated as settled.
Has industry downplayed plastic chemical harms?
The record shows a clear funding pattern. When researchers counted the low-dose BPA studies through 2005, more than nine in ten government-funded studies found significant effects while none of the industry-funded ones did, and some industry studies discounted their own positive controls or used designs unlikely to show an effect. That pattern is part of why the regulatory picture trailed the independent science for years. The practical lesson is modest: where an additive is easy to avoid, the case for avoiding it does not rest on any single agency's timeline.
Do microplastics cause cancer in humans?
This has not been established. The cancer concern centers on certain plastic building-block chemicals in industrial settings, such as vinyl chloride, rather than on the finished-plastic particles most people encounter, and whether everyday microplastic exposure changes cancer risk in people is still an open research question. Detection of particles in the body is exposure, not proven harm. The clearer, better-supported harms of the plastic chemicals are hormonal, and the reduction steps on this page lower that exposure regardless of how the cancer question resolves.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 14 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 10, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.